$ALGN
ALIGN TECHNOLOGY INC Stock $algn

$algn Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000109714924000033 Filed on May 03, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$1.028B	$997.4M	$943.1M
YoY Change	2.63%	5.76%	-3.09%
Cost Of Revenue	$305.9M	$299.6M	$282.5M
YoY Change	5.99%	6.06%	7.06%
Gross Profit	$722.6M	$697.8M	$660.7M
YoY Change	1.26%	5.63%	-6.86%
Gross Profit Margin	70.26%	69.96%	70.05%
Selling, General & Admin	$452.3M	$451.8M	$439.7M
YoY Change	-0.21%	2.76%	0.05%
% of Gross Profit	62.59%	64.75%	66.55%
Research & Development	$92.19M	$91.86M	$87.45M
YoY Change	4.19%	5.05%	21.78%
% of Gross Profit	12.76%	13.16%	13.24%
Depreciation & Amortization	$36.17M	$32.95M	$35.82M
YoY Change	0.97%	-8.02%	20.91%
% of Gross Profit	5.0%	4.72%	5.42%
Operating Expenses	$544.5M	$543.7M	$527.1M
YoY Change	0.51%	3.14%	3.1%
Operating Profit	$178.2M	$154.1M	$133.5M
YoY Change	3.63%	15.44%	-32.6%
Interest Expense	$3.301M	$4.392M	$2.337M
YoY Change	-25.33%	87.93%	245.2%
% of Operating Profit	1.85%	2.85%	1.75%
Other Income/Expense, Net	-$6.481M	-$141.0K	-$1.229M
YoY Change	36.07%	-88.53%	-89.1%
Pretax Income	$143.9M	$158.4M	$134.6M
YoY Change	-16.16%	17.65%	-28.2%
Income Tax	$47.30M	$53.36M	$46.83M
% Of Pretax Income	32.88%	33.69%	34.78%
Net Earnings	$96.56M	$105.0M	$87.80M
YoY Change	-13.64%	19.62%	-34.62%
Net Earnings / Revenue	9.39%	10.53%	9.31%
Basic Earnings Per Share	$1.28	$1.40	$1.14
Diluted Earnings Per Share	$1.28	$1.39	$1.14
COMMON SHARES
Basic Shares Outstanding	75.28M shares	75.10M shares	76.61M shares
Diluted Shares Outstanding	75.22M shares	75.32M shares	77.11M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$782.1M	$898.9M	$884.0M
YoY Change	-22.39%	1.68%	-12.72%
Cash & Equivalents	$761.4M	$865.8M	$832.4M
Short-Term Investments	$20.68M	$33.10M	$51.64M
Other Short-Term Assets	$350.6M	$349.6M	$251.5M
YoY Change	48.22%	38.98%	678.06%
Inventory	$259.5M	$280.1M	$311.9M
Prepaid Expenses	$91.26M	$72.19M	$84.36M
Receivables	$1.020B	$950.7M	$884.4M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.412B	$2.479B	$2.332B
YoY Change	-2.15%	6.32%	-6.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.400B	$1.401B	$1.381B
YoY Change	-0.35%	1.45%	21.02%
Goodwill	$454.5M	$458.2M	$414.2M
YoY Change	9.58%	10.63%	0.55%
Intangibles	$115.7M	$121.4M	$93.32M
YoY Change	29.57%	30.12%	-9.83%
Long-Term Investments	$0.00	$3.619M	$37.38M
YoY Change	-100.0%	-90.32%	-65.29%
Other Assets	$1.776B	$1.692B	$1.644B
YoY Change	1.82%	2.95%	2749.46%
Total Long-Term Assets	$3.746B	$3.676B	$3.570B
YoY Change	1.82%	2.99%	3.09%
TOTAL ASSETS
Total Short-Term Assets	$2.412B	$2.479B	$2.332B
Total Long-Term Assets	$3.746B	$3.676B	$3.570B
Total Assets	$6.158B	$6.156B	$5.901B
YoY Change	0.22%	4.31%	-0.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$105.8M	$117.2M	$130.6M
YoY Change	-3.96%	-10.2%	-30.0%
Accrued Expenses	$555.5M	$496.6M	$497.2M
YoY Change	-7.45%	-0.13%	6.92%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.040B	$2.023B	$2.005B
YoY Change	-3.18%	0.92%	7.56%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$360.3M	$372.9M	$416.8M
YoY Change	-9.74%	-10.54%	125.96%
Total Long-Term Liabilities	$360.3M	$372.9M	$416.8M
YoY Change	-9.74%	-10.54%	125.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.040B	$2.023B	$2.005B
Total Long-Term Liabilities	$360.3M	$372.9M	$416.8M
Total Liabilities	$2.400B	$2.396B	$2.421B
YoY Change	-4.22%	-1.05%	6.36%
SHAREHOLDERS EQUITY
Retained Earnings	$2.457B	$2.503B	$2.374B
YoY Change	-1.16%	5.44%	-11.45%
Common Stock	$7.000K	$7.000K	$8.000K
YoY Change	-12.5%	-12.5%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.758B	$3.760B	$3.480B
YoY Change
Total Liabilities & Shareholders Equity	$6.158B	$6.156B	$5.901B
YoY Change	0.22%	4.31%	-0.71%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$96.56M	$105.0M	$87.80M
YoY Change	-13.64%	19.62%	-34.62%
Depreciation, Depletion And Amortization	$36.17M	$32.95M	$35.82M
YoY Change	0.97%	-8.02%	20.91%
Cash From Operating Activities	$159.8M	$28.66M	$199.9M
YoY Change	-36.52%	-85.66%	555.44%
INVESTING ACTIVITIES
Capital Expenditures	$53.45M	$9.369M	$64.12M
YoY Change	-8.7%	-85.39%	-26.58%
Acquisitions		$77.08M	$0.00
YoY Change
Other Investing Activities	-$59.04M	$6.000K	-$6.000K
YoY Change	-11.8%	-200.0%	-100.24%
Cash From Investing Activities	-$112.5M	-$79.58M	-$52.83M
YoY Change	-10.35%	50.64%	-41.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-151.6M	-$11.72M	-$259.0M
YoY Change	16179.16%	-95.48%	131.75%
NET CHANGE
Cash From Operating Activities	159.8M	$28.66M	$199.9M
Cash From Investing Activities	-112.5M	-$79.58M	-$52.83M
Cash From Financing Activities	-151.6M	-$11.72M	-$259.0M
Net Change In Cash	-104.2M	-$71.64M	-$109.7M
YoY Change	-183.14%	-34.68%	-36.7%
FREE CASH FLOW
Cash From Operating Activities	$159.8M	$28.66M	$199.9M
Capital Expenditures	$53.45M	$9.369M	$64.12M
Free Cash Flow	$106.4M	$19.30M	$135.8M
YoY Change	-44.95%	-85.79%	-338.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	299615000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	282493000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	697816000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	660654000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	451822000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	439691000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	91859000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	87447000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	543681000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	527138000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	154135000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	133516000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	4392000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	2337000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-141000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1229000	usd
CY2024Q1	algn	Interest Income And Other Income Expense Net InterestIncomeAndOtherIncomeExpenseNet	4251000	usd
CY2023Q1	algn	Interest Income And Other Income Expense Net InterestIncomeAndOtherIncomeExpenseNet	1108000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	158386000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	134624000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53358000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46826000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	105028000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	87798000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.40
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.14
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.39
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.14
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75175000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76921000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75322000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77111000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	105028000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	87798000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2932000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	10474000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	203000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1645000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2729000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12119000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	102299000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	99917000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	865805000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	937438000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	33101000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	35304000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16026000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	14893000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	950738000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	903424000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	280076000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	296902000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	349594000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	273550000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	2479314000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2446618000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	3619000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	8022000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1281709000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1290863000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118996000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	117999000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	458235000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	419530000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	121424000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	82118000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1570626000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1590045000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	121831000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	128682000	usd
CY2024Q1	us-gaap	Assets Assets	6155754000	usd
CY2023Q4	us-gaap	Assets Assets	6083877000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	117238000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	113125000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	496601000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	525780000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1409202000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1427706000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2023041000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2066611000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	121314000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	116744000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	95092000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	96968000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	156447000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	173065000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	2395894000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2453388000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75281000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75281000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75075000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75075000	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1238739000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1162140000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	18439000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	21168000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2502675000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2447174000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	3759860000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3630489000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6155754000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6083877000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3630489000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	105028000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	203000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2932000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14339000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	26055000	usd
CY2024Q1	algn	Adjustments To Additional Paid In Capital Accelerated Repurchase Agreement Remaining Contract Value AdjustmentsToAdditionalPaidInCapitalAcceleratedRepurchaseAgreementRemainingContractValue	0	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38788000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	3759860000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3601358000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	87798000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1645000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	10474000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14256000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	20857000	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	292360000	usd
CY2023Q1	algn	Adjustments To Additional Paid In Capital Accelerated Repurchase Agreement Remaining Contract Value AdjustmentsToAdditionalPaidInCapitalAcceleratedRepurchaseAgreementRemainingContractValue	-40000000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	37735000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3480049000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	105028000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	87798000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	18047000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-18417000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32946000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	35820000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	38788000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	37735000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	9612000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	7755000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2359000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-11586000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	69589000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32734000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-15573000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-24008000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	79160000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	26850000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4100000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5993000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-34473000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	37420000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4570000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2119000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-14419000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	27662000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	28664000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	199895000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	77075000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9369000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64119000	usd
CY2024Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	2371000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	6035000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10870000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	831000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2785000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	6000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-6000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-79584000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-52829000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	14339000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	14256000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	292360000	usd
CY2024Q1	algn	Proceeds From Payments For Equity Forward Contracts Related To Accelerated Stock Repurchase Agreements ProceedsFromPaymentsForEquityForwardContractsRelatedToAcceleratedStockRepurchaseAgreements	0	usd
CY2023Q1	algn	Proceeds From Payments For Equity Forward Contracts Related To Accelerated Stock Repurchase Agreements ProceedsFromPaymentsForEquityForwardContractsRelatedToAcceleratedStockRepurchaseAgreements	40000000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	26055000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	20857000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11716000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-258961000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9004000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2221000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-71640000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-109674000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	938519000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	942355000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	866879000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	832681000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the U.S. requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, useful lives of intangible assets and property and equipment, long-lived assets and goodwill, income taxes, contingent liabilities, the fair values of financial instruments, stock-based compensation and the valuation of investments in privately held companies, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div>
CY2024Q1	algn	Cash And Cash Equivalents And Debt Securities Available For Sale Amortized Cost CashAndCashEquivalentsAndDebtSecuritiesAvailableForSaleAmortizedCost	903061000	usd
CY2024Q1	algn	Cash And Cash Equivalents And Debt Securities Available For Sale Gross Unrealized Gain CashAndCashEquivalentsAndDebtSecuritiesAvailableForSaleGrossUnrealizedGain	3000	usd
CY2024Q1	algn	Cash And Cash Equivalents And Debt Securities Available For Sale Gross Unrealized Loss CashAndCashEquivalentsAndDebtSecuritiesAvailableForSaleGrossUnrealizedLoss	539000	usd
CY2024Q1	algn	Cash And Cash Equivalents And Debt Securities Available For Sale CashAndCashEquivalentsAndDebtSecuritiesAvailableForSale	902525000	usd
CY2023Q4	algn	Cash And Cash Equivalents And Debt Securities Available For Sale Amortized Cost CashAndCashEquivalentsAndDebtSecuritiesAvailableForSaleAmortizedCost	981569000	usd
CY2023Q4	algn	Cash And Cash Equivalents And Debt Securities Available For Sale Gross Unrealized Gain CashAndCashEquivalentsAndDebtSecuritiesAvailableForSaleGrossUnrealizedGain	7000	usd
CY2023Q4	algn	Cash And Cash Equivalents And Debt Securities Available For Sale Gross Unrealized Loss CashAndCashEquivalentsAndDebtSecuritiesAvailableForSaleGrossUnrealizedLoss	812000	usd
CY2023Q4	algn	Cash And Cash Equivalents And Debt Securities Available For Sale CashAndCashEquivalentsAndDebtSecuritiesAvailableForSale	980764000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	32515000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	34617000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	4205000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	8709000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	36720000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	43326000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	7641000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	39000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	26719000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	500000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	34360000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	539000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	7065000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	23000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	32612000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	789000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	39677000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	812000	usd
CY2024Q1	us-gaap	Accounts Receivable Sale AccountsReceivableSale	14600000	usd
CY2023Q1	us-gaap	Accounts Receivable Sale AccountsReceivableSale	8000000.0	usd
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	86301000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	93082000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	134305000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	145492000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	92518000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	91259000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	53253000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	60151000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	280076000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	296902000	usd
CY2024Q1	algn	Tax Related Receivables TaxRelatedReceivables	206915000	usd
CY2023Q4	algn	Tax Related Receivables TaxRelatedReceivables	143728000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	72187000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	52487000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	70492000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	77335000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	349594000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	273550000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	191904000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	220862000	usd
CY2024Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	76540000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	71109000	usd
CY2024Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	42933000	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	34035000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	38942000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	38103000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31324000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	29651000	usd
CY2024Q1	algn	Accrued Fixed Assets Current AccruedFixedAssetsCurrent	16093000	usd
CY2023Q4	algn	Accrued Fixed Assets Current AccruedFixedAssetsCurrent	23618000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	98865000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	108402000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	496601000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	525780000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	22426000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	17873000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	5449000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	4532000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	3312000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	3476000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	24563000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	18929000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	66023000	usd
CY2024Q1	algn	Finite Lived Intangible Assets Accumulated Impairment Loss FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	8450000	usd
CY2024Q1	algn	Finite Lived Intangible Assets Net Before Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsNetBeforeForeignCurrencyTranslationGainLoss	123158000	usd
CY2024Q1	algn	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss1 FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss1	-1734000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1409202000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1427706000	usd
CY2024Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	115400000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	138000000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	997400000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	943100000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	236800000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	205700000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1533100000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	419530000	usd
CY2024Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	47673000	usd
CY2024Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-8968000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	458235000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	197631000	usd
CY2023Q4	us-gaap	Restructuring Charges RestructuringCharges	14000000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	121424000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	156662000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	67081000	usd
CY2023Q4	algn	Finite Lived Intangible Assets Accumulated Impairment Loss FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	8450000	usd
CY2023Q4	algn	Finite Lived Intangible Assets Net Before Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsNetBeforeForeignCurrencyTranslationGainLoss	81131000	usd
CY2023Q4	algn	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss1 FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss1	987000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	82118000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	13977000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	18574000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	17969000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	15607000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	14505000	usd
CY2024Q1	algn	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	42526000	usd
CY2024Q1	algn	Finite Lived Intangible Assets Net Before Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsNetBeforeForeignCurrencyTranslationGainLoss	123158000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5000000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4100000	usd
CY2019Q1	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	3	claim
CY2024Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	575000	usd
CY2022Q4	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	63000000	usd
CY2023Q3	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	63000000	usd
CY2023Q3	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	63000000	usd
	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	95000000	usd
CY2024Q1	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	115000000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38788000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	37735000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53400000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46800000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.337
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.348
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	150800000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	149200000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	5300000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	105028000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	87798000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75175000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76921000	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	147000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	190000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75322000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77111000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.40
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.14
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.39
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.14
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	571000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	578000	shares
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	21284000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	30907000	usd
CY2024Q1	algn	Noncash Settlement Of Stock Repurchase Forward Contract NoncashSettlementOfStockRepurchaseForwardContract	50000	usd
CY2023Q1	algn	Noncash Settlement Of Stock Repurchase Forward Contract NoncashSettlementOfStockRepurchaseForwardContract	0	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	9998000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	7871000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	10568000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5559000	usd
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	997431000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	943147000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	697816000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	660654000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	154135000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	133516000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	38788000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	37735000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32946000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	35820000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	154135000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	133516000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	4392000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	2337000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-141000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1229000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	158386000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	134624000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	997431000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	943147000	usd
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	1400705000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1408862000	usd
CY2024Q1	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	-3900000	usd
CY2024Q1	us-gaap	Restructuring Reserve RestructuringReserve	1400000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001097149-24-000033-index-headers.html	Edgar Link	pending
0001097149-24-000033-index.html	Edgar Link	pending
0001097149-24-000033.txt	Edgar Link	pending
0001097149-24-000033-xbrl.zip	Edgar Link	pending
algn-20240331.htm	Edgar Link	pending
algn-20240331.xsd	Edgar Link	pending
algn-20240331xex311.htm	Edgar Link	pending
algn-20240331xex312.htm	Edgar Link	pending
algn-20240331xex321.htm	Edgar Link	pending
algn-20240331_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
algn-20240331_cal.xml	Edgar Link	unprocessable
algn-20240331_def.xml	Edgar Link	unprocessable
algn-20240331_lab.xml	Edgar Link	unprocessable
algn-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
algn-20240331_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALGN
ALIGN TECHNOLOGY INC Stock $algn

2024 Q2 Form 10-Q Financial Statement

#000109714924000033 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALGN ALIGN TECHNOLOGY INC Stock $algn

2024 Q2 Form 10-Q Financial Statement

#000109714924000033 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALGN
ALIGN TECHNOLOGY INC Stock $algn